High plating density improves Big Blue® system efficiency without loss of sensitivity

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 453, Issue 1, 2000, Pages 97-103

  Heinmöller, Petra W ^a   Hill, Kathleen A ^a   Sommer, Steve S ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

lacI; Methodological advances; Mutation frequency; Sequencing

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLOR; CONTROLLED STUDY; COST CONTROL; DATA BASE; DNA SEQUENCE; ESCHERICHIA COLI; FEMALE; LIVER CELL; MOUSE; MUTATION; MUTATION RATE; NONHUMAN; PLAQUE FORMING CELL; PRIORITY JOURNAL; SPONTANEOUS MUTATION; TRANSGENIC MOUSE;

ANIMAL; BACTERIAL PROTEINS; FEMALE; MICE; MICE, TRANSGENIC; MUTAGENICITY TESTS; REPRESSOR PROTEINS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0343714691     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(00)00091-9     Document Type: Article

References (19)

1. Hill K.A., Buettner V.L., Glickman B.W., Sommer S.S. Spontaneous mutations in the Big Blue transgenic system are primarily mouse derived. Mutat. Res. Minirev. 436:1999;11-19.
2. de Boer J.G., Glickman B.W. The lacI gene as a target for mutation in transgenic rodents Escherichia coli. Genetics. 148:1998;1441-1451.
3. Kohler S.W., Provost G.S., Kretz P.L., Fieck A., Sorge J.A., Short J.M. The use of transgenic mice for short-term, in vivo mutagenicity testing. GATA. 7:1990;212-218.
4. Rogers B.J., Provost G.S., Young R., Putman D.L, Short J.M. Intralaboratory optimization and standardization of mutant screening conditions used for a lambda/lacI transgenic mouse mutagenesis assay. Mutat. Res. 327:1995;57-66.
5. Buettner V., Hill K.A., Halangoda A., Sommer S.S. Tandem-based mutations occur in mouse liver and adipose tissue preferentially as G:C to T:A transversions and accumulate with age. Environ. Mol. Mutagen. 33:1999;320-324.
6. Nishino H., Knöll A., Buettner V.L., Frisk C.S., Maruta Y., Haavik J., Sommer S.S. p53 wild-type and p53 nullizygous Big Blue transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain. Oncogene. 11:1995;263-270.
7. Hill K.A., Nishino H., Buettner V.L., Halangoda A., Li W., Sommer S.S. The Big Blue transgenic mouse mutation detection assay: the mutation pattern of sectored mutant plaques. Mutat. Res. 425:1999;47-54.
8. Nishino H., Buettner V.L., Haavik J., Schaid D.J., Sommer S.S. Spontaneous mutation in Big Blue transgenic mice: analysis of age, gender and tissue type. Environ. Mol. Mutagen. 28:1996;299-312.
9. Nishino H., Schaid D.J., Buettner V.L., Haavik J., Sommer S.S. Mutation frequencies but not mutant frequencies in Big Blue mice fit a poisson distribution. Environ. Mol. Mutagen. 28:1996;414-417.
10. Knöll A., Jacobson D.P., Kretz P.L., Lundberg K.S., Short J.M., Sommer S.S. Spontaneous mutations in lacI-containing lambda lysogens derived from transgenic mice: the observed patterns differ in liver and spleen. Mutat. Res. 311:1994;57-67.
11. TM lacI transgenic mouse system: what happens to the mutational spectra over time? Mutat. Res. 352:1996;9-22.
12. Lundberg K.S., Kretz P.L., Provost G.S., Short J.M. The use of selection in recovery of transgenic targets for mutation analysis. Mutat. Res. 301:1993;99-105.
13. Bressac B., Kew M., Wands J., Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature. 350:1991;429-431.
14. Okonogi H., Ushijima T., Zhang X.B., Heddle J.A., Suzuki T., Sofuni T., Felton J.S., Tucker J.D., Sigumura T., Nagao M. Agreement of mutational characteristics of heterocyclic amines in lacI of the Big Blue mouse with those in tumor related genes in rodents. Carcinogenesis. 18:1997;745-748.
15. Okochi E., Watanabe N., Shimada Y., Takahashi S., Wakazono K., Shirai T., Sugimura T., Nagao M., Ushijima T. Preferential induction of guanine deletion at 5′-GGGA-3′ in rat mammary glands by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Carcinogenesis. 20:1999;1933-1938.
16. Monroe J., Kort K., Miller J., Marino D., Skopek T. A comparative study of in vivo mutation assays: analysis of hprt, lacI and cII/cI as mutational targets for N-nitroso-N-methylurea and Benzo[α]pyrene in Big Blue mice. Mutat. Res. 421:1998;121-136.
17. Harbach P.R., Zimmer D.M., Filipunas A.L., Mattes W.B., Aaron C.S. Spontaneous mutation spectrum at the lambda cII locus in liver, lung and spleen tissue of Big Blue transgenic mice. Environ. Mol. Mutagen. 33:1999;132-143.
18. Shane B.S., Cunningham M.L. Comparison of the mutant frequency (MF) of lacI and of cII in the liver of Big Blue transgenic mice treated with diethylnitrosamine (DEN). Environ. Mol. Mutagen. 31S29:1998;14.
19. Zimmer D.M., Mattes W.B., Aaron C.S. Spontaneous and ENU-induced cII mutation spectra in Big Blue mice. Environ. Mol. Mutagen. 31S29:1998;14.